Corient Private Wealth’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.72M Buy
121,597
+92,752
+322% +$2.42M ﹤0.01% 1185
2026
Q1
$763K Buy
28,845
+21,905
+316% +$777K ﹤0.01% 1799
2025
Q4
$289K Buy
+6,940
New +$282K ﹤0.01% 2193
2025
Q3
Sell
-5,403
Closed -$286K 2581
2025
Q2
$286K Buy
+5,403
New +$285K ﹤0.01% 2020
2024
Q2
Sell
-3,858
Closed -$255K 2330
2024
Q1
$255K Sell
3,858
-5,430
-58% -$441K ﹤0.01% 1982
2023
Q4
$912K Buy
9,288
+3,043
+49% +$265K ﹤0.01% 1322
2023
Q3
$501K Buy
6,245
+255
+4% +$20K ﹤0.01% 1499
2023
Q2
$484K Sell
5,990
-1,697
-22% -$159K ﹤0.01% 1464
2023
Q1
$934K Buy
7,687
+29
+0.4% +$3.94K ﹤0.01% 1112
2022
Q4
$1.02M Buy
+7,658
New +$931K ﹤0.01% 907

Other funds holding CNXC

Corient Private Wealth's CNXC Position: Q2 2026 in Review

Corient Private Wealth increased its Concentrix (CNXC) stake by 322% in Q2 2026, buying an estimated $2.42M and bringing the position to 121,597 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1185.

Corient Private Wealth first reported a position in CNXC in Q4 2022 and has held it in 10 quarters since. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Corient Private Wealth held 121,597 shares of Concentrix worth $2.72M as of Q2 2026.
  • Corient Private Wealth bought 92,752 Concentrix shares in Q2 2026, an estimated $2.42M.
  • Concentrix made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1185 holding.
  • Corient Private Wealth first reported a position in Concentrix in Q4 2022 and has held it in 10 quarters since.
  • 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.